logo

Beta Agonist Feed Additive Market Size (2024 - 2029)

The beta agonist feed additive market is experiencing growth driven by increasing meat consumption and the associated rise in cattle production, particularly in North America, which holds a significant share of the market. The health benefits offered by these additives are contributing to their widespread use in livestock, including ruminants and swine. This trend is expected to continue, influencing the overall market size and share in the coming years.

Home Market Analysis Animal Nutrition & Wellness Research Feed Additives Research Beta-Agnostic Feed Additives Research Beta Agonist Feed Additive Market Market Size

Market Size of Beta Agonist Feed Additive Industry

Beta Agonist Feed Additive Market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 2.80 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Beta Agonist Feed Additive Market Key players

*Disclaimer: Major Players sorted in no particular order

Beta Agonist Feed Additives Market Analysis

The Global Beta Agonist Feed Additive Market is projected to grow at a CAGR of 2.8% during the forecast period (2020-2025). North America to dominate the beta-agonist feed additive market by garnering nearly 77% of the global sales in 2018. According to the US Department of Agriculture (USDA), the year 2018 set a record of 222.2 pounds per capita of animal meat being consumed in the United States, breaking the previous year's record of 216.9 pounds per capita. The growing consumption of meat is expected to stimulate the production of cattle, which in turn, may bolster the US beta-agonist feed additives market in the forecast period. 60-80% of the US fed cattle are raised with a beta-agonist, like Optaflexx (ractopamine hydrochloride) sold by Elanco Animal Health or Zilmax (zilpaterol hydrochloride) manufactured by Merck Animal Health. The increasing demand for animal meat, including ruminant and swine meat around the world, and the health benefits of beta-agonist feed additives are some of the major driving factors for the global beta-agonist feed additive market.

Beta Agonist Feed Additives Industry Segmentation

Beta-agonists feed additives are used to feed ruminants and swine, especially before slaughtering. They are approved feed additives, which help in escalating lean muscle gain, increase growth rate, and feed efficiency. The report presents an in-depth analysis of the market share, size, and trends of the global beta-agonist feed additive market. It comprises a comprehensive analysis of market segmentation on the basis of types of feed additives and animal types for which, feed additives are used.

Type
Ractopamine
Zilpaterol
Animal Type
Swine
Ruminants
Others
Geography
North America
United States
Canada
Mexico
Rest of North America
Asia-Pacific
Japan
South Korea
India
Rest of Asia-Pacific
South America
Brazil
Argentina
Rest of South America
Rest of the World
Need A Different Region Or Segment?
Customize Now

Beta Agonist Feed Additive Market Size Summary

The beta agonist feed additive market is experiencing steady growth, driven by the increasing global demand for meat and high-value animal protein. This demand is fueled by factors such as population growth, rising incomes in developing nations, and urbanization, which have led to a surge in livestock production. The market is characterized by the use of beta-agonists like Optaflexx and Zilmax, which are integral in enhancing cattle production. North America, particularly the United States, dominates the market due to its high per capita meat consumption and significant use of beta-agonists in cattle farming. Despite challenges such as the discontinuation of Zilmax, the market remains robust, with Optaflexx maintaining a strong presence.

Globally, the meat market continues to grow, with the highest consumption increases expected in the Asia-Pacific and Latin American regions. This growth is attributed to changing dietary patterns, urbanization, and economic development. The beta agonist feed additive market is relatively concentrated, with few key players like Merck Animal Health, Elanco Animal Health, and Zoetis offering similar products. These companies are focusing on innovation to maintain a competitive edge. The market's expansion is supported by the ongoing need to meet the rising demand for meat, particularly in urban areas where consumption is increasing faster than in rural regions.

Explore More

Beta Agonist Feed Additive Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Powers of Buyers

      2. 1.4.2 Bargaining Powers of Suppliers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitutes

      5. 1.4.5 Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Type

      1. 2.1.1 Ractopamine

      2. 2.1.2 Zilpaterol

    2. 2.2 Animal Type

      1. 2.2.1 Swine

      2. 2.2.2 Ruminants

      3. 2.2.3 Others

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

        4. 2.3.1.4 Rest of North America

      2. 2.3.2 Asia-Pacific

        1. 2.3.2.1 Japan

        2. 2.3.2.2 South Korea

        3. 2.3.2.3 India

        4. 2.3.2.4 Rest of Asia-Pacific

      3. 2.3.3 South America

        1. 2.3.3.1 Brazil

        2. 2.3.3.2 Argentina

        3. 2.3.3.3 Rest of South America

      4. 2.3.4 Rest of the World

Beta Agonist Feed Additive Market Size FAQs

The Beta Agonist Feed Additive Market is projected to register a CAGR of 2.80% during the forecast period (2024-2029)

Merck Animal Health, Elanco Animal Health, Zoetis, Quality Liquid Feeds and Heer Pharma Private Limited are the major companies operating in the Beta Agonist Feed Additive Market.

Beta Agonist Feed Additive Report Snapshots

Beta Agonist Feed Additive Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)